{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:37:58Z","timestamp":1767022678145,"version":"3.48.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,29]]},"DOI":"10.7759\/cureus.100339","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:33:48Z","timestamp":1767022428000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Anorganic Bone Matrix Combined With a P-15 Osteogenic Cell-Binding Peptide (ABM\/P-15) in One- and Two-Level Transforaminal Lumbar Interbody Fusion (TLIF): A Propensity-Matched Comparison"],"prefix":"10.7759","author":[{"given":"Mitsuhiro","family":"Nishizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D","family":"Glassman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mladen","family":"Djurasovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Gum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R","family":"Dimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Kirk","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Carreon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1051624","article-title":"A one-stager procedure in operative treatment of spondylolistheses: dorsal traction-reposition and anterior fusion (author's transl) [Article in German]","volume":"120","author":"Harms J","year":"1982","unstructured":"Harms J, Rolinger H. A one-stager procedure in operative treatment of spondylolistheses: dorsal traction-reposition and anterior fusion (author's transl) [Article in German]. Z Orthop Ihre Grenzgeb. 1982, 120:343-7. 10.1055\/s-2008-1051624","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-023-06131-4","article-title":"Is local autogenous morselized bone harvested from decompression through a posterior-transforaminal approach sufficient for single-level interbody fusion in the lower lumbar spine?","volume":"24","author":"Yang J","year":"2023","unstructured":"Yang J, Yang Y, Wang G, et al.. Is local autogenous morselized bone harvested from decompression through a posterior-transforaminal approach sufficient for single-level interbody fusion in the lower lumbar spine?. BMC Musculoskelet Disord. 2023, 24:12. 10.1186\/s12891-023-06131-4","journal-title":"BMC Musculoskelet Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.brs.0000215048.51237.3c","article-title":"Outcome of local bone versus autogenous iliac crest bone graft in the instrumented posterolateral fusion of the lumbar spine","volume":"31","author":"Sengupta DK","year":"2006","unstructured":"Sengupta DK, Truumees E, Patel CK, Kazmierczak C, Hughes B, Elders G, Herkowitz HN. Outcome of local bone versus autogenous iliac crest bone graft in the instrumented posterolateral fusion of the lumbar spine. Spine (Phila Pa 1976). 2006, 31:985-91. 10.1097\/01.brs.0000215048.51237.3c","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000000867","article-title":"The fate of L5-S1 with low-dose BMP-2 and pelvic fixation, with or without interbody fusion, in adult deformity surgery","volume":"40","author":"Annis P","year":"2015","unstructured":"Annis P, Brodke DS, Spiker WR, Daubs MD, Lawrence BD. The fate of L5-S1 with low-dose BMP-2 and pelvic fixation, with or without interbody fusion, in adult deformity surgery. Spine (Phila Pa 1976). 2015, 40:E634-9. 10.1097\/BRS.0000000000000867","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-024-07531-w","article-title":"Pseudarthrosis risk factors in lumbar fusion: a systematic review and meta-analysis","volume":"25","author":"Boonsirikamchai W","year":"2024","unstructured":"Boonsirikamchai W, Wilartratsami S, Ruangchainikom M, Korwutthikulrangsri E, Tongsai S, Luksanapruksa P. Pseudarthrosis risk factors in lumbar fusion: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2024, 25:433. 10.1186\/s12891-024-07531-w","journal-title":"BMC Musculoskelet Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1570749","article-title":"Iliac crest bone graft versus local autograft or allograft for lumbar spinal fusion: a systematic review","volume":"6","author":"Tuchman A","year":"2016","unstructured":"Tuchman A, Brodke DS, Youssef JA, et al.. Iliac crest bone graft versus local autograft or allograft for lumbar spinal fusion: a systematic review. Global Spine J. 2016, 6:592-606. 10.1055\/s-0035-1570749","journal-title":"Global Spine J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2009.05.006","article-title":"Prospective study of iliac crest bone graft harvest site pain and morbidity","volume":"9","author":"Kim DH","year":"2009","unstructured":"Kim DH, Rhim R, Li L, et al.. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J. 2009, 9:886-92. 10.1016\/j.spinee.2009.05.006","journal-title":"Spine J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3171\/2014.4.SPINE14325","article-title":"Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion","volume":"21","author":"Kaiser MG","year":"2014","unstructured":"Kaiser MG, Groff MW, Watters WC 3rd, et al.. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion. J Neurosurg Spine. 2014, 21:106-32. 10.3171\/2014.4.SPINE14325","journal-title":"J Neurosurg Spine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24655","article-title":"History of bone grafts in spine surgery","volume":"14","author":"Hampel GA","year":"2022","unstructured":"Hampel GA, Yilmaz E, Massrey C, Clifton W, Iwanaga J, Loukas M, Tubbs RS. History of bone grafts in spine surgery. Cureus. 2022, 14:e24655. 10.7759\/cureus.24655","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rboe.2016.03.005","article-title":"The use of bone morphogenetic proteins (BMP) and pseudarthrosis, a literature review","volume":"52","author":"Oliveira OR","year":"2017","unstructured":"Oliveira OR, Martins SP, Lima WG, Gomes MM. The use of bone morphogenetic proteins (BMP) and pseudarthrosis, a literature review. Rev Bras Ortop. 2017, 52:124-40. 10.1016\/j.rboe.2016.03.005","journal-title":"Rev Bras Ortop"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/jss-22-23","article-title":"Recombinant human bone morphogenetic protein-2 in spine surgery: recommendations for use and alternative bone substitutes-a narrative review","volume":"8","author":"Malham GM","year":"2022","unstructured":"Malham GM, Louie PK, Brazenor GA, Mobbs RJ, Walsh WR, Sethi RK. Recombinant human bone morphogenetic protein-2 in spine surgery: recommendations for use and alternative bone substitutes-a narrative review. J Spine Surg. 2022, 8:477-90. 10.21037\/jss-22-23","journal-title":"J Spine Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.112466","article-title":"FDA-approved bone grafts and bone graft substitute devices in bone regeneration","volume":"130","author":"Gillman CE","year":"2021","unstructured":"Gillman CE, Jayasuriya AC. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C Mater Biol Appl. 2021, 130:112466. 10.1016\/j.msec.2021.112466","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2009.04.004","article-title":"Complications associated with single-level transforaminal lumbar interbody fusion","volume":"9","author":"Rihn JA","year":"2009","unstructured":"Rihn JA, Patel R, Makda J, et al.. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J. 2009, 9:623-9. 10.1016\/j.spinee.2009.04.004","journal-title":"Spine J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2016.06.007","article-title":"RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose","volume":"16","author":"Villavicencio AT","year":"2016","unstructured":"Villavicencio AT, Burneikiene S. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose. Spine J. 2016, 16:1208-13. 10.1016\/j.spinee.2016.06.007","journal-title":"Spine J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/21925682231166325","article-title":"Comparative complications associated with BMP use in patients undergoing ACDF for degenerative spinal conditions: systematic review and meta-analysis","volume":"14","author":"Martin CT","year":"2024","unstructured":"Martin CT, Holton K, Broida SE, et al.. Comparative complications associated with BMP use in patients undergoing ACDF for degenerative spinal conditions: systematic review and meta-analysis. Global Spine J. 2024, 14:94S-109S. 10.1177\/21925682231166325","journal-title":"Global Spine J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3171\/2021.3.FOCUS2152","article-title":"Impact of surgeon rhBMP-2 cost awareness on complication rates and health system costs for spinal arthrodesis","volume":"50","author":"McGrath M","year":"2021","unstructured":"McGrath M, Feroze AH, Nistal D, Robinson E, Saigal R. Impact of surgeon rhBMP-2 cost awareness on complication rates and health system costs for spinal arthrodesis. Neurosurg Focus. 2021, 50:E5. 10.3171\/2021.3.FOCUS2152","journal-title":"Neurosurg Focus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2003.12.007","article-title":"Comparison of cell viability on anorganic bone matrix with or without P-15 cell binding peptide","volume":"25","author":"Hanks T","year":"2004","unstructured":"Hanks T, Atkinson BL. Comparison of cell viability on anorganic bone matrix with or without P-15 cell binding peptide. Biomaterials. 2004, 25:4831-6. 10.1016\/j.biomaterials.2003.12.007","journal-title":"Biomaterials"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.1997.10508155","article-title":"The role in cell binding of a beta-bend within the triple helical region in collagen alpha 1 (I) chain: structural and biological evidence for conformational tautomerism on fiber surface","volume":"14","author":"Bhatnagar RS","year":"1997","unstructured":"Bhatnagar RS, Qian JJ, Gough CA. The role in cell binding of a beta-bend within the triple helical region in collagen alpha 1 (I) chain: structural and biological evidence for conformational tautomerism on fiber surface. J Biomol Struct Dyn. 1997, 14:547-60. 10.1080\/07391102.1997.10508155","journal-title":"J Biomol Struct Dyn"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000001466","article-title":"Efficacy of i-Factor bone graft versus autograft in anterior cervical discectomy and fusion: results of the prospective, randomized, single-blinded Food and Drug Administration investigational device exemption study","volume":"41","author":"Arnold PM","year":"2016","unstructured":"Arnold PM, Sasso RC, Janssen ME, et al.. Efficacy of i-Factor bone graft versus autograft in anterior cervical discectomy and fusion: results of the prospective, randomized, single-blinded Food and Drug Administration investigational device exemption study. Spine (Phila Pa 1976). 2016, 41:1075-83. 10.1097\/BRS.0000000000001466","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002290","article-title":"Six-year follow-up of a randomized controlled trial of i-factor peptide-enhanced bone graft versus local autograft in single-level anterior cervical discectomy and fusion","volume":"92","author":"Arnold PM","year":"2023","unstructured":"Arnold PM, Vaccaro AR, Sasso RC, et al.. Six-year follow-up of a randomized controlled trial of i-factor peptide-enhanced bone graft versus local autograft in single-level anterior cervical discectomy and fusion. Neurosurgery. 2023, 92:725-33. 10.1227\/neu.0000000000002290","journal-title":"Neurosurgery"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003947","article-title":"The evolution, current value, and future of the American Society of Anesthesiologists physical status classification system","volume":"135","author":"Horvath B","year":"2021","unstructured":"Horvath B, Kloesel B, Todd MM, Cole DJ, Prielipp RC. The evolution, current value, and future of the American Society of Anesthesiologists physical status classification system. Anesthesiology. 2021, 135:904-19. 10.1097\/ALN.0000000000003947","journal-title":"Anesthesiology"},{"key":"ref22","article-title":"The Oswestry low back pain disability questionnaire","volume":"66","author":"Fairbank JC","year":"1980","unstructured":"Fairbank JC, Couper J, Davies JB, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980, 66:271-3.","journal-title":"Physiotherapy"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-200011150-00017","article-title":"The Oswestry Disability Index","volume":"25","author":"Fairbank JC","year":"2000","unstructured":"Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000, 25:2940-52; discussion 2952. 10.1097\/00007632-200011150-00017","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.37.4.378","article-title":"Studies with pain rating scales","volume":"37","author":"Downie WW","year":"1978","unstructured":"Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Ann Rheum Dis. 1978, 37:378-81. 10.1136\/ard.37.4.378","journal-title":"Ann Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino RB Jr","year":"1998","unstructured":"D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998, 17:2265. 10.1002\/(sici)1097-0258(19981015)17:19&lt;2265::aid-sim918&gt;3.0.co;2-b","journal-title":"Stat Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin PC","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011, 10:150-61. 10.1002\/pst.433","journal-title":"Pharm Stat"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3171\/2014.9.SPINE131151","article-title":"Clinical outcomes and fusion rates following anterior lumbar interbody fusion with bone graft substitute i-FACTOR, an anorganic bone matrix\/P-15 composite","volume":"21","author":"Mobbs RJ","year":"2014","unstructured":"Mobbs RJ, Maharaj M, Rao PJ. Clinical outcomes and fusion rates following anterior lumbar interbody fusion with bone graft substitute i-FACTOR, an anorganic bone matrix\/P-15 composite. J Neurosurg Spine. 2014, 21:867-76. 10.3171\/2014.9.SPINE131151","journal-title":"J Neurosurg Spine"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2020.01.009","article-title":"Randomized double blind clinical trial of ABM\/P-15 versus allograft in noninstrumented lumbar fusion surgery","volume":"20","author":"Jacobsen MK","year":"2020","unstructured":"Jacobsen MK, Andresen AK, Jespersen AB, St\u00f8ttrup C, Carreon LY, Overgaard S, Andersen M\u00d8. Randomized double blind clinical trial of ABM\/P-15 versus allograft in noninstrumented lumbar fusion surgery. Spine J. 2020, 20:677-84. 10.1016\/j.spinee.2020.01.009","journal-title":"Spine J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/21925682221090924","article-title":"Safety and reoperation rates in non-instrumented lumbar fusion surgery: secondary report from a randomized controlled trial of ABM\/P-15 vs allograft with minimum 5 years follow-up","volume":"14","author":"Andresen AK","year":"2024","unstructured":"Andresen AK, Carreon LY, Overgaard S, Jacobsen MK, Andersen M\u00d8. Safety and reoperation rates in non-instrumented lumbar fusion surgery: secondary report from a randomized controlled trial of ABM\/P-15 vs allograft with minimum 5 years follow-up. Global Spine J. 2024, 14:33-40. 10.1177\/21925682221090924","journal-title":"Global Spine J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.14444\/2002","article-title":"Prospective analysis of a new bone graft in lumbar interbody fusion: results of a 2- year prospective clinical and radiological study","volume":"9","author":"Lauweryns P","year":"2015","unstructured":"Lauweryns P, Raskin Y. Prospective analysis of a new bone graft in lumbar interbody fusion: results of a 2- year prospective clinical and radiological study. Int J Spine Surg. 2015, 9:10.14444\/2002","journal-title":"Int J Spine Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2021.0296","article-title":"Comparative analysis of ABM\/P-15, bone morphogenic protein and demineralized bone matrix after instrumented lumbar interbody fusion","volume":"65","author":"Sathe A","year":"2022","unstructured":"Sathe A, Lee SH, Kim SJ, et al.. Comparative analysis of ABM\/P-15, bone morphogenic protein and demineralized bone matrix after instrumented lumbar interbody fusion. J Korean Neurosurg Soc. 2022, 65:825-33. 10.3340\/jkns.2021.0296","journal-title":"J Korean Neurosurg Soc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-009-1046-1","article-title":"The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis","volume":"18","author":"Rihn JA","year":"2009","unstructured":"Rihn JA, Makda J, Hong J, et al.. The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis. Eur Spine J. 2009, 18:1629-36. 10.1007\/s00586-009-1046-1","journal-title":"Eur Spine J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3171\/2015.4.SPINE141086","article-title":"Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery","volume":"24","author":"Hofstetter CP","year":"2016","unstructured":"Hofstetter CP, Hofer AS, Levi AD. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery. J Neurosurg Spine. 2016, 24:457-75. 10.3171\/2015.4.SPINE141086","journal-title":"J Neurosurg Spine"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-200208151-00010","article-title":"Safety profile for the clinical use of bone morphogenetic proteins in the spine","volume":"27","author":"Poynton AR","year":"2002","unstructured":"Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976). 2002, 27:S40-8. 10.1097\/00007632-200208151-00010","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2017.03.003","article-title":"BMP-2-induced bone formation and neural inflammation","volume":"14","author":"Nguyen V","year":"2017","unstructured":"Nguyen V, Meyers CA, Yan N, Agarwal S, Levi B, James AW. BMP-2-induced bone formation and neural inflammation. J Orthop. 2017, 14:252-6. 10.1016\/j.jor.2017.03.003","journal-title":"J Orthop"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s002640100262","article-title":"Orthopaedic applications of osteogenic protein-1 (BMP-7)","volume":"25","author":"Pecina M","year":"2001","unstructured":"Pecina M, Giltaij LR, Vukicevic S. Orthopaedic applications of osteogenic protein-1 (BMP-7). Int Orthop. 2001, 25:203-8. 10.1007\/s002640100262","journal-title":"Int Orthop"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/BF02533457","article-title":"Cholesteryl ester and triacylglycerol fatty acids in type V hyperlipidemia","volume":"14","author":"Jensen RG","year":"1979","unstructured":"Jensen RG, Clark RM, Gerrior SA, Fey MB, Gotto AM Jr. Cholesteryl ester and triacylglycerol fatty acids in type V hyperlipidemia. Lipids. 1979, 14:691-4. 10.1007\/BF02533457","journal-title":"Lipids"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/01.brs.0000143623.18098.e5","article-title":"A biomechanical study of regional endplate strength and cage morphology as it relates to structural interbody support","volume":"29","author":"Lowe TG","year":"2004","unstructured":"Lowe TG, Hashim S, Wilson LA, O'Brien MF, Smith DA, Diekmann MJ, Trommeter J. A biomechanical study of regional endplate strength and cage morphology as it relates to structural interbody support. Spine (Phila Pa 1976). 2004, 29:2389-94. 10.1097\/01.brs.0000143623.18098.e5","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref39","article-title":"Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety","volume":"12","author":"Martin GJ Jr","year":"1999","unstructured":"Martin GJ Jr, Boden SD, Marone MA, Marone MA, Moskovitz PA. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord. 1999, 12:179-86.","journal-title":"J Spinal Disord"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.6.2220","article-title":"Recombinant human bone morphogenetic protein induces bone formation","volume":"87","author":"Wang EA","year":"1990","unstructured":"Wang EA, Rosen V, D'Alessandro JS, et al.. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A. 1990, 87:2220-4. 10.1073\/pnas.87.6.2220","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/01.brs.0000116588.17129.b9","article-title":"Two-year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient","volume":"29","author":"Cammisa FP Jr","year":"2004","unstructured":"Cammisa FP Jr, Lowery G, Garfin SR, et al.. Two-year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient. Spine (Phila Pa 1976). 2004, 29:660-6. 10.1097\/01.brs.0000116588.17129.b9","journal-title":"Spine (Phila Pa 1976)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/431582-clinical-outcomes-of-anorganic-bone-matrix-combined-with-a-p-15-osteogenic-cell-binding-peptide-abmp-15-in-one--and-two-level-transforaminal-lumbar-interbody-fusion-tlif-a-propensity-matched-comparison","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:33:50Z","timestamp":1767022430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/431582-clinical-outcomes-of-anorganic-bone-matrix-combined-with-a-p-15-osteogenic-cell-binding-peptide-abmp-15-in-one--and-two-level-transforaminal-lumbar-interbody-fusion-tlif-a-propensity-matched-comparison"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.100339","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,29]]}}}